Tuberculosis (TB)

The New Challenge for TB Research

An ancient disease, TB remains one of the major causes of disability and death worldwide. In 2006, 9.2 million new cases of TB emerged and TB killed 1.7 million people. NIAID is examining TB at its fundamental levels through research aimed at developing faster diagnostic tools, better vaccines, and shorter treatment times.

Multidrug-resistant and Extensively Drug-resistant Tuberculosis Research Agenda (PDF)

NIAID’s Role in Addressing Tuberculosis (TB), Drug-Resistant TB, and TB in People with HIV/AIDS

		TB Research at NIAID
		Research Goals Basic Research Diagnostic Research Advances in Treatment Prevention: Vaccine Development Global Research Scientific Illustrations of Drug-Resistant TB NIAID Labs Networks, Consortia and Partners Resources Training Meetings Scientific Literature